Approval · Notice of Compliance 36347 · 2025
AA-METHYLPHENIDATE SR: Notice of Compliance 36347
Issued November 7, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 36347
- Date
- November 7, 2025
- Company
- AA Pharma Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Labelling Only
- Reason
- Product Monograph reformatted to the Master Template Change in product ownership Change in product name
- Canadian reference product
- RITALIN SR (Novartis Pharmaceuticals Canada Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| AA-METHYLPHENIDATE SR | 02266687 | Marketed |
Medicinal ingredients
- METHYLPHENIDATE HYDROCHLORIDE 20 MG per TAB